Home Infusion Therapy Market Size Worth USD 83.31 Billion by 2034 | CAGR: 8.0%

The home infusion therapy market size is expected to reach USD 83.31 billion by 2034, according to a new study by Polaris Market Research. The report “Home Infusion Therapy Market Size, Share, Trend, Industry Analysis Report By Type (Product, Service), By Application (Anti-infective, Endocrinology, Hydration Therapy, Chemotherapy, Enteral Nutrition, Parenteral Nutrition), By Region – Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The home infusion therapy market refers to the administration of medications through intravenous or subcutaneous routes in a patient’s home setting, rather than in hospitals or infusion centers. This approach supports patient convenience, lowers healthcare costs, and reduces hospital-acquired infection risks. The increasing prevalence of chronic diseases such as cancer, immune deficiencies, and gastrointestinal disorders has accelerated demand for home-based treatment alternatives. Payers and healthcare systems are pushing for outpatient and home care models to curb rising inpatient costs, reinforcing adoption of infusion services delivered outside traditional clinical settings. The market growth is also supported by the development of compact, user-friendly infusion pumps and digital health tools that enable remote monitoring and virtual care integration.

Questions? Request a sample or make an inquiry before buying this report by clicking the link below: https://www.polarismarketresearch.com/industry-analysis/home-infusion-therapy-market/request-for-sample

Ongoing advancements in biologics and specialty drugs tailored for chronic disease management boost the need for reliable home infusion protocols. Physician acceptance and reimbursement clarity have significantly improved, enabling broader patient eligibility. Pharmaceutical companies and service providers are forming value-based partnerships to bundle drug delivery with ongoing care management, enhancing patient adherence and therapeutic outcomes. The home infusion therapy market is witnessing increased focus on service personalization, leveraging patient-centric logistics and education.

Opportunities exist in expanding therapeutic areas, including hormonal therapies, pain management, and rare disease treatments, where infusion is clinically required and frequent hospital visits are burdensome. The integration of telehealth and automated documentation systems is transforming operational efficiency, allowing providers to manage high patient volumes while maintaining care quality. Home infusion continues to evolve as a key component in long-term care strategies and decentralized healthcare delivery.

Top of FormHome Infusion Therapy Market Report Highlights

• By type, the service segment accounted for ~72% of the revenue share in 2024, due to the growing need for skilled nursing, pharmacy support, and on-site administration expertise in home settings.
• Based on application, the anti-infective segment accounted for the largest revenue share in 2024, due to the widespread use of intravenous antibiotics to treat infections such as osteomyelitis, cellulitis, and endocarditis in outpatient settings.
• North America accounted for ~57% share of the home infusion therapy market revenue in 2024 due to strong healthcare infrastructure, widespread insurance coverage, and an aging population requiring long-term care.
• The Asia Pacific market is expected to grow significantly from 2025 to 2034 due to rising healthcare awareness, urbanization, and efforts to decentralize medical care.
• A few global key players include Amedisys, Inc.; B. Braun SE; Baxter; BD; CareCentrix, Inc.; Coram LLC.; Fresenius Kabi AG; ICU Medical, Inc.; JMS Co. Ltd.; Moog Inc.; Option Care Health, Inc.; PharMerica Corporation; and Terumo Corporation.

Polaris Market Research has segmented the home infusion therapy market on the basis of type, application, and region:

By Type Outlook (Revenue, USD Billion, 2020–2034)

• Product
  • Infusion Pumps
• Elastomeric
• Electromechanical
• Gravity
• Others
  • Intravenous Sets
  • IV Cannulas
  • Needleless Connectors
• Services

By Application Outlook (Revenue, USD Billion, 2020–2034)

• Anti-Infective
• Endocrinology
  • Diabetes
  • Others
• Hydration Therapy
• Chemotherapy
• Enteral Nutrition
• Parenteral Nutrition
• Specialty Pharmaceuticals
• Others

By Regional Outlook (Revenue, USD Billion, 2020–2034)

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Vietnam
  • Australia
  • Rest of Asia Pacific
• Latin America
  • Argentina
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
  • Rest of Middle East & Africa